true

Healthcare-associated infections (HAI)

Solutions to support your efforts to address HAI risk factors

Banner
Overview

Helping you standardize and optimize along your HAI management journey

Day in and day out, you strive to provide the highest quality care and improve the lives of patients. However, HAIs constantly threaten to undermine your best efforts. We believe the most effective approach to HAIs is a holistic one—focused on mitigating risk factors, optimizing infection identification and advancing and monitoring treatment strategies.

From assessment and training on safe and effective use of products to advanced informatics and analytic tools, we help you standardize technologies, processes and practices to reduce care variation. 

Challenges

HAIs continue to be one of the most common complications of hospital care.

  • Stat - 1 in 31

    1 in 31 hospital patients has at least one HAI 1

  • Stat - ~1 in 10

    ~1 in 10 patients with an HAI died during their hospitalization1*

  • Stat - ~6x

    Median length of stay in the hospital increased by up to 6x for patients with an HAI2

  • Stat - ~42%

    ~42% of patients with an HAI are readmitted within 30 days2**

  • Stat - $21-33 billion

    Excess healthcare costs caused by HAIs3

HAI Types

Many HAIs are preventable

Implementing evidence-based prevention strategies can lead to up to a 70 percent reduction in certain HAIs.4†

  • HOB is a bloodstream infection from a bacterial or fungal pathogen that is first identified on or after the 4th calendar day of hospital admission.5
  • This type of HAI is not limited to a specific device or source.

A catheter that clinicians often place in a large vein in the neck, chest, or groin to give medication or fluids or to collect blood for medical tests.7

A CLABSI is a serious infection that occurs when pathogen (bacteria, fungus or virus) enters the bloodstream through a central line.7

  • On average, up to 82 patients a day in the U.S. acquire a CLABSI.10
  •  CLABSIs result in thousands of deaths (approximately 1 in 4 CLABSIs) each year and billions of dollars in added costs to the U.S. healthcare system.9, 11
  • Substandard catheter care, such as excessive manipulation of the catheter, is associated with an increased risk for CLABSI.12
  • All CLABSIs acquired on day four or later during a hospital admission are a subset of HOB.13
  • Although CLABSIs have been a primary focus, all vascular access devices can introduce risk for bloodstream infections, including peripherally inserted IV catheters.14

A urinary tract infection (UTI) is an infection involving any part of the urinary system, including urethra, bladder, ureters and kidney.6

  • 75% of UTIs acquired in the hospital are associated with a urinary catheter, which is a tube inserted into the bladder through the urethra to drain urine.6
  • 15-25% of hospitalized patients receive urinary catheters during their hospital stay.6
  • Each day an indwelling urinary catheter remains, a patient has a 3-7% increased risk of acquiring a CAUTI; most important risk factor for developing a CAUTI is prolonged use of the urinary catheter.6,7
  • Eight percent of CAUTIs may evolve into HOB.8 For every CAUTI that evolves into HOB, three non-CAUTI hospital-onset UTIs may do the same. This highlights urine as a major source of HOB both with and without indwelling catheters.8

An SSI is an infection that occurs after surgery in the part of the body where the surgery took place.7 Surgical site infections can involve the skin only, more serious infections can involve tissues under the skin, organs or implanted material.7

  • SSIs are now one of the most common and most costly HAIs and occur in 1-3% of patients undergoing inpatient surgery.15
  • Approximately 160,000-300,000 occur each year in the U.S.12
  • Up to 50% of SSIs have been estimated to be preventable by using evidence-based guidelines.16
  • Patients with an SSI have a 2-11x higher risk of death compared to operative patients without SSI.15 Also, 77% of deaths in patients with SSI are directly attributable to SSI.15
  • Surgical risk factors include prolonged procedures and inadequacies in surgical scrub, antiseptic preparation of the skin and surgical irrigation practice.17
  • The incidence of HOB may be 6x higher in admissions with SSIs.18
Explore

Take a collaborative approach


            

Overview Overview
Overview
Assess Assess
Assess
Improve Improve
Improve
Maintain Maintain
Maintain
  • Identify and prioritize improvement areas 
  • Coordinate clinical support programs 
  • Measure and sustain performance

Review current practices, policies and technologies to establish a baseline and track performance

Create a joint implementation plan based on recommendations from baseline assessment of how BD solutions can address identified gaps and improve performance in people, processes and technologies

Sustain best practice through standardized workflows, hospital champions, and ongoing education and training

urological.jpg

Urological drainage management

Address errors and variations in urine Foley catheter usage by focusing on product training and education

Learn more
vascular.jpg
Vascular access management

Advance vascular access care by helping to reduce complications for peripheral and central intravenous (IV) access

Learn more
surgical.jpg
Surgical solutions

Help increase patient safety and lower costs through improved surgical processes

Learn more
diagnostic.jpg
Diagnostic accuracy and efficiency

Set the patient on the right clinical path through timely and accurate diagnosis

Learn more
HAI.jpg
HAI informatics and analytics

Highlight and prioritize improvement opportunities, track interventions and outcomes to help inform process improvement, and empower clinician-led patient outcomes

Learn more
Resources

Interested in learning more?

Interested in learning more?
References

†Results from the U.S. in 2011

  1. Centers for Disease Control and Prevention. Healthcare-associated infections. CDC. Published 2024. Accessed May 8, 2025 at https://www.cdc.gov/healthcare-associated-infections/php/data/index.html.
  2. Pennsylvania Health Care Cost Containment Council (PHC4). The Impact of Healthcare-associated Infections in Pennsylvania 2010. Pennsylvania Health Care Cost Containment Council (PHC4). Accessed: Feb 2012
  3. Agency for Healthcare Research and Quality (AHRQ). Healthcare-associated infections. AHRQ. Updated March 2019. Accessed June 10, 2025. https://www.ahrq.gov/professionals/quality-patient-safety/patient-safety-resources/resources/hais/index.html
  4. Miller, MA, Umscheid CA, Dowell J, Schone E. Prevalence and burden of healthcare-associated infections (HAIs), 2016-2021. HCUP Statistical Brief #313. Agency for Healthcare Research and Quality. Published October 2024. Accessed May 8, 2025 at http://hcup-us-ahrq.gov/reports/statbriefs/sb313-prevalence-burden-HAIs-2016-2021.pdf.
  5. Schrank GM, Snyder GM, Leekha S. Hospital-onset bacteremia and fungemia: examining healthcare-associated infections prevention through a wider lens. Antimicrob Steward Healthc Epidemiol. 2023 Nov 8;3(1):e198. doi: 10.1017/ash.2023.486. PMID: 38028924; PMCID: PMC10654956
  6. Centers for Disease Control and Prevention. Catheter-associated Urinary Tract Infections (CAUTI). Centers for Disease Control and Prevention. Available at https://www.cdc.gov/hai/ca_uti/uti.html. Accessed March 30, 2020.
  7. Centers for Disease Control and Prevention. Antibiotic Resistance & Patient Safety Portal: Healthcare-Associated Infections. Centers for Disease Control and Prevention. Available at https://arpsp.cdc.gov/profile/infections?tab=nhsn. Accessed March 30, 2020.
  8. Kelly T, Ai C, Jung M, Yu K. Catheter-associated urinary tract infections (CAUTIs) and non-CAUTI hospital-onset urinary tract infections: Relative burden, cost, outcomes and related hospital-onset bacteremia and fungemia infections. Infect Control Hosp Epidemiol. 2024 Jul;45(7):864-871. doi: 10.1017/ice.2024.26. Epub 2024 Feb 20. PMID: 38374686; PMCID: PMC11439594.
  9. Centers for Disease Control and Prevention. Central Line-associated Bloodstream Infections: Resources for Patients and Healthcare Providers. Centers for Disease Control and Prevention. Available at https://www.cdc.gov/hai/bsi/clabsi-resources.html. Page last reviewed: February 7, 2011
  10. Centers for Disease Control and Prevention. Bloodstream Infection Event. Centers for Disease Control and Prevention. Available at https://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf. Page last reviewed: January 2020
  11. Centers for Disease Control and Prevention. Vital signs: central line-associated blood stream infections—United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011;60(8):243-248
  12. Society for Healthcare Epidemiology of America (SHEA) Healthcare-Associated Infections: A Compendium of Prevention Recommendations. Available at https://www.guidelinecentral.com/guideline/12717/#ifc7c9a35. Copyright 2014. (PDF file)
  13. Yu KC, Jung M, Ai C. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals. Infect Control Hosp Epidemiol. 2023;44(12):1920-1926. doi:10.1017/ice.2023.132
  14. World Health Organization. Global Report on Infection Prevention and Control. World Health Organization; 2022. Accessed June 10, 2025. https://www.who.int/publications/i/item/9789240093829
  15. Calderwood MS, Anderson DJ, Bratzler DW, et al. Strategies to prevent surgical site infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2023;44(5):695-720. doi:10.1017/ice.2023.67
  16. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784-791. doi:10.1001/jamasurg.2017.0904 Published correction appears in JAMA Surg. 2017;152(8):803.
  17. Cheadle WG. Risk factors for surgical site infection. Surg Infect (Larchmt). 2006;7 Suppl 1:S7-S11. doi:10.1089/sur.2006.7.s1-7
  18. Ai C, Jung M, Bastow S, Adjaoute G, Bostick D, Yu KC. Clinical outcomes and hospital-reported cost associated with surgical site infections and the co-occurrence of hospital-onset bacteremia and fungemia across US hospitals. Infect Control Hosp Epidemiol. 2025 Feb 19;46(4):1-7. doi: 10.1017/ice.2025.13. Epub ahead of print. PMID: 39967257; PMCID: PMC12015625.
Healthcare-associated infections (HAI) Thumbnail Image Administrator,Laboratorian,Pharmacist,Surgeon,Clinician BD logo

Solutions to support your efforts to address HAI risk factors